Internal Medicine, Infectious Disease · Bronx, NY
NPI
1518493436
Since 2017
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1650 Selwyn Ave
Bronx, NY, 10457
Phone (718) 992-7669
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
198 services
Medicare patients, 2024
93
Average age 69
Drug cost, 2024
$3.2M
3,454 prescriptions
Company payments, 2025
$14.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sabirah N Kasule was code 99214 (office e&m - established), 61 times for 32 patients. In total Sabirah N Kasule billed 198 services in 12 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 61 | 32 | $73.00 | $4,453 |
| 99233 Hospital E&M - Subsequent | Facility | 47 | 28 | $104.75 | $4,923 |
| 99223 Hospital E&M - Initial | Facility | 40 | 38 | $152.84 | $6,113 |
| 99213 Office E&M - Established | Facility | 26 | 19 | $54.50 | $1,417 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $116.10 | $1,277 |
By year: 2022 $5,744 for 63 services; 2023 $20K for 209 services; 2024 $19K for 198 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sabirah N Kasule prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 360 prescriptions and refills. In total Sabirah N Kasule wrote 3,454 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 360 | 362 | 47 | $1.4M |
| Atorvastatin Calcium Generic | 238 | 296 | 40 | $1,710 |
| Amlodipine Besylate Generic | 225 | 253 | 32 | $796 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 136 | 160 | 29 | $4,649 |
| Juluca Dolutegravir/Rilpivirine | 104 | 104 | 17 | $363K |
| Dovato Dolutegravir Sodium/Lamivudine | 95 | 95 | 13 | $276K |
| Zolpidem Tartrate Generic | 76 | 76 | 11 | $554 |
| Gabapentin Generic | 74 | 100 | 18 | $870 |
| Omeprazole Generic | 73 | 89 | 14 | $410 |
| Lisinopril Generic | 73 | 77 | 14 | $173 |
| Rosuvastatin Calcium Generic | 64 | 66 | Under 11 | $534 |
| Metformin Hcl Generic | 57 | 65 | Under 11 | $152 |
| Valacyclovir Valacyclovir Hcl | 57 | 59 | 12 | $1,256 |
| Prezcobix Darunavir/Cobicistat | 57 | 57 | Under 11 | $144K |
| Pravastatin Sodium Generic | 56 | 68 | Under 11 | $391 |
Brand drugs: 1,180 claims; generic drugs: 2,260 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sabirah N Kasule $14.06 ($14.06 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $14.06.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $14.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.